Evidence map›Paper›PMID 42436115›Full record

ArticleNature communications2026

Invas: an inversion-aware method for transcriptome assembly.

Xuedong Wang, Feiyue Wang, Chenzhao Feng, Chaoyang Sun, Shuaicheng Li

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xuedong Wang *Department of Computer Science, City University of Hong Kong, Hong Kong, China.
Feiyue Wang *Department of Computer Science, City University of Hong Kong, Hong Kong, China.
Chenzhao Feng *Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.ORCID http://orcid.org/0000-0001-6018-7768
Chaoyang SunDepartment of Obstetrics and Gynecology, National Clinical Research Center for Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. suncydoctor@gmail.com.ORCID http://orcid.org/0000-0003-2469-1638
Shuaicheng LiDepartment of Computer Science, City University of Hong Kong, Hong Kong, China. shuaicli@cityu.edu.hk.ORCID http://orcid.org/0000-0002-0620-9353

Funding

National Natural Science Foundation of China (National Science Foundation of China) 32270687
6 · The paper itself

Abstract

Intragenic inversions reverse sequence orientation within genes and create non-collinear splice junctions that standard transcript assemblers miss, resulting in incomplete reconstruction and biased quantification. Here we show Invas, an inversion-aware framework operating with bulk short-read sequencing data. Invas integrates whole-genome sequencing breakpoints with transcriptomic sequencing evidence, rescues unmapped reads, and assembles isoforms using conjugate flow optimization. In silico across 42,000 events, Invas demonstrates high precision and recall and improves quantification of unaffected transcripts compared with conventional tools. We apply Invas to seven disease cohorts, identifying recurrent germline susceptibility variants and somatic drivers. Furthermore, Invas facilitates the discovery of somatic inversion-derived tumor-specific antigens with strong predicted immunogenicity. We release Invas and InvasDB as community resources to enable accurate characterization of inversion-affected genes, filling a critical gap in structural variant-aware transcriptomics.

Indexed as

Gene Expression ProfilingTranscriptomeHumansWhole Genome Sequencing

Identifiers

PMID42436115
PMCPMC13484493

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.